江中药业：聘任徐永前为公司总经理

Group 1 - The core point of the article is the management changes at Jiangzhong Pharmaceutical, with the resignation of the general manager and CFO, and the appointment of new executives [1] - Jiangzhong Pharmaceutical's revenue composition for the first half of 2025 shows that the pharmaceutical industry accounts for 99.64%, while the liquor industry and other businesses account for 0.25% and 0.11% respectively [1] - The company's market capitalization is reported to be 15 billion yuan [2]